[
    [
        {
            "time": "2019-09-11",
            "original_text": "【IPO追踪】复星旗下复宏汉霖(02696-HK)明起招股入场费5838港元",
            "features": {
                "keywords": [
                    "IPO",
                    "复宏汉霖",
                    "招股",
                    "入场费"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【IPO追踪】复星旗下复宏汉霖(02696-HK)明起招股入场费5838港元",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-09-11",
            "original_text": "【异动股】单抗概念板块下挫，九洲药业(603456-CN)跌5.87%",
            "features": {
                "keywords": [
                    "单抗概念",
                    "九洲药业",
                    "下跌"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【异动股】单抗概念板块下挫，九洲药业(603456-CN)跌5.87%",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-09-11",
            "original_text": "复宏汉霖明天启动招股 卡塔尔投资局及高管成为基石投资者",
            "features": {
                "keywords": [
                    "复宏汉霖",
                    "招股",
                    "卡塔尔投资局",
                    "基石投资者"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复宏汉霖明天启动招股 卡塔尔投资局及高管成为基石投资者",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-09-11",
            "original_text": "复星医药(600196.SH)：复宏汉霖更新聆讯后资料集",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "聆讯后资料集"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药(600196.SH)：复宏汉霖更新聆讯后资料集",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-09-11",
            "original_text": "医药业转型提速 创新发展添彩“健康中国”",
            "features": {
                "keywords": [
                    "医药业",
                    "转型",
                    "创新发展",
                    "健康中国"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药业转型提速 创新发展添彩“健康中国”",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-09-11",
            "original_text": "【IPO追踪】复星医药(02196-HK)拟分拆复宏汉霖主板上市",
            "features": {
                "keywords": [
                    "IPO",
                    "复星医药",
                    "复宏汉霖",
                    "分拆",
                    "主板上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【IPO追踪】复星医药(02196-HK)拟分拆复宏汉霖主板上市",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-09-11",
            "original_text": "【金财富决策参考】2019-09-11",
            "features": {
                "keywords": [
                    "金财富",
                    "决策参考"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【金财富决策参考】2019-09-11",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 2,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 4,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        }
    ]
]